The JAK2 V617F mutation in Philadelphia‐negative chronic myeloproliferative disorders
AUTOR(ES)
Stój, Anastazja
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1972424Documentos Relacionados
- Philadelphia-negative chronic myeloproliferative neoplasms
- A mutação JAK2 V617F e as síndromes mieloproliferativas
- Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
- Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F
- Molecular biology of Philadelphia-negative myeloproliferative neoplasms
